IMGT Co.,Ltd. Company Description

IMGT Co.,Ltd. engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.

It develops IMGT-LPS, a technology that injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into the body and releases drugs by irradiating ultrasound to the target area(tumor); IMGT-EMB, a nanoparticle for chemoembolization of liver cancer; IMGT-TSD, a targeted sonodynamic therapy that induces immune boosting mechanism by applying ultrasonic stimulation to the cancerous area; and IMGT-FUS, a device for non-invasive treatment.

The company was founded in 2010 and is based in Seongnam-si, South Korea.

IMGT Co.,Ltd.

Country	South Korea
Founded	2010
Industry	Biological Products, Except Diagnostic Substances
CEO	Hakjong Lee

Contact Details

Address: 408, Healthcare Innovation Park Seongnam-si, 13605 South Korea
Phone	82 3 1994 7077
Website	nanoimgt.com

Stock Details

Ticker Symbol	456570
Exchange	Korea New Exchange
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Hakjong Lee	Chief Executive Officer